Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07015424 · ClinicalTrials.gov registry record · NA

Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass

A NA study of Weight Loss and Weight Regain, sponsored by Boston Scientific Corporation.

Recruiting
Registry status
NA
Development phase
108
Enrollment target
10
Study locations

NCT07015424: Recruiting NA study of Weight Loss and Weight Regain, sponsored by Boston Scientific Corporation.

NCT07015424 is a NA study of Weight Loss and Weight Regain that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 108 participants, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (93% lower). The trial reports 10 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07015424, a NA study of Weight Loss and Weight Regain, is actively recruiting participants, sponsored by Boston Scientific Corporation.

RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target
10
Study locations

Study Summary

The goal of this clinical trial is to evaluate weight loss with TORe and intensive lifestyle modification versus intensive lifestyle modification alone in subjects who have regained weight following a Roux-en-Y gastric bypass. Participants will randomized 2:1. Those randomized to the TORe arm will receive a TORe procedure and intensive lifestyle modification which consists of a well-balanced calorie restrictive diet, incorporation of exercise and coaching on lifestyle discussion. Participants randomized the lifestyle modification alone arm will be eligible to receive a TORe procedure at 6 months post enrollment. Total follow up will be 24 months.

Primary Outcome

The percent TBWL that subjects achieve at 6 months post-randomization

Interventions

  • DEVICE TORe with OverStitch
  • BEHAVIORAL Intensive lifestyle modification

Study Locations (10)

Florida

  • Mayo Clinic - Jacksonville
  • Orlando Health Inc - Orlando
  • University of South Florida - Tampa

California

  • Hoag Memorial Hospital - Irvine
  • Stanford University Medical Center - Stanford

Illinois

  • Rush University Medical Center - Chicago

Massachusetts

  • Brigham and Women's Hospital - Boston

Minnesota

  • Mayo Clinic Foundation - Rochester

New York

  • NYU Grossman School of Medicine - New York

Texas

  • University of Texas Houston Health Science Center - Houston

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2026-02
Est. Completion 2028-11
Phase NA
Boston Scientific Corporation

280 total trials

What NCT07015424 shows while recruiting

NCT07015424 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (93% lower).

The record links to 2 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which TORe with OverStitch is the first listed.

NCT07015424 lists 10 locations in 7 states (Florida, California, Illinois).

Frequently Asked Questions

What is clinical trial NCT07015424 about?

NCT07015424 is a clinical study titled "Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass". The goal of this clinical trial is to evaluate weight loss with TORe and intensive lifestyle modification versus intensive lifestyle modification alone in subjects who have regained weight following a Roux-en-Y gastric bypass. Participants will randomized 2:1. Those randomized to the TORe arm will ...

What is the current status of trial NCT07015424?

This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2026-02. Estimated completion is 2028-11.

What conditions does trial NCT07015424 study?

This clinical trial studies the following conditions: Weight Loss, Weight Regain.

What interventions are being tested in trial NCT07015424?

The interventions under investigation include: TORe with OverStitch (DEVICE), Intensive lifestyle modification (BEHAVIORAL).

Who is sponsoring clinical trial NCT07015424?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07015424 being conducted?

This trial has 10 study locations across California, Florida, Illinois, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07015424's enrollment target sits among peer trials

108 44th of 116 higher than 73 of 116 other Weight Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07015424, the US trial registry maintained by the National Library of Medicine. NCT07015424 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.